# William G. Herrington

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/william-g-herrington/

## Facts

| Field | Value |
| --- | --- |
| Citations | 27,709 |
| Field | Chronic Kidney Disease and Diabetes |
| h-index | 61 |
| i10-index | 134 |
| Last Known Institution | Churchill Hospital |
| OpenAlex ID | https://openalex.org/A5078477384 |
| ORCID iD | https://orcid.org/0000-0003-1172-8243 |
| Works | 275 |

## Researcher papers

Showing 12 of 13.

- [KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease](https://scholariq.org/papers/kdigo-2024-clinical-practice-guideline-for-the-evaluation-and-management-of/)
- [The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial](https://scholariq.org/papers/the-effects-of-lowering-ldl-cholesterol-with-simvastatin-plus-ezetimibe-in/)
- [2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes](https://scholariq.org/papers/2023-esc-guidelines-for-the-management-of-cardiovascular-disease-in-patients/)
- [Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials](https://scholariq.org/papers/impact-of-diabetes-on-the-effects-of-sodium-glucose-co-transporter-2-inhibitors/)
- [Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials](https://scholariq.org/papers/efficacy-and-safety-of-statin-therapy-in-older-people-a-meta-analysis-of/)
- [Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns](https://scholariq.org/papers/executive-summary-of-the-kdigo-2024-clinical-practice-guideline-for-the-3/)
- [Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies](https://scholariq.org/papers/change-in-albuminuria-and-subsequent-risk-of-end-stage-kidney-disease-an/)
- [SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe](https://scholariq.org/papers/score2-diabetes-10-year-cardiovascular-risk-estimation-in-type-2-diabetes-in/)
- [Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy](https://scholariq.org/papers/second-asymptomatic-carotid-surgery-trial-acst-2-a-randomised-comparison-of/)
- [The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study](https://scholariq.org/papers/the-potential-for-improving-cardio-renal-outcomes-by-sodium-glucose-co/)
- [A meta-analysis of GFR slope as a surrogate endpoint for kidney failure](https://scholariq.org/papers/a-meta-analysis-of-gfr-slope-as-a-surrogate-endpoint-for-kidney-failure/)
- [Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease—Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/challenges-in-conducting-clinical-trials-in-nephrology-conclusions-from-a-kidney/)

## Researcher topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

## Researcher university

- [Churchill Hospital](https://scholariq.org/institutions/churchill-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.